• Our People
  • Global Presence
  • Regions
    • Asia
    • Europe
    • Americas
  • Offices
    • Canada
      • Ottawa
      • Toronto
    • China
      • Beijing
      • Hong Kong
    • Luxembourg
    • Malaysia
    • Singapore
    • UK
      • Aberdeen
      • Birmingham
      • Cambridge
      • Edinburgh
      • Glasgow
      • London
      • Manchester
      • Oxford
  • Client liaison
    • Japan
    • Korea
  • Expertise
  • Services
    • Patents
    • Brands & Trade Marks
    • Designs
    • Litigation & Dispute Resolution
    • Commercial IP & Contracts
    • Due Diligence
    • Freedom to Operate
    • EPO Patent Oppositions
    • European Patent Validations
    • Anti-counterfeiting
    • Open Source & Third Party Code
  • Sectors
    • Energy & Environment
    • Life Sciences
    • Agritech
    • Medical Technologies
    • Chemistry
    • Transport
    • Entertainment & Creative Industries
    • Food & Drink
    • Fashion & Retail
    • Universities & Research Bodies
    • Start-ups & Spin-outs
    • Digital Transformation
      • 3D Printing
      • Artificial Intelligence
      • Blockchain
      • Data & Connectivity
      • Extended Reality
      • Industry 4.0
  • About Us
    • Working with us
    • Awards
    • Corporate & Social Responsibility
    • Diversity & Inclusion
    • Careers
  • Insights
    • Articles
    • News
    • Events
    • Resources
    • M&C Reacts
  • Contact Us
Marks & Clerk logo
Marks & Clerk logo
Contact Us
Language
English
Our People
Global Presence
Regions
  • Asia
  • Europe
  • Americas
Offices
  • Canada
    • Ottawa
    • Toronto
  • China
    • Beijing
    • Hong Kong
  • Luxembourg
  • Malaysia
  • Singapore
  • UK
    • Aberdeen
    • Birmingham
    • Cambridge
    • Edinburgh
    • Glasgow
    • London
    • Manchester
    • Oxford
Client liaison
  • Japan
  • Korea
Expertise
Services
  • Patents
  • Brands & Trade Marks
  • Designs
  • Litigation & Dispute Resolution
  • Commercial IP & Contracts
  • Due Diligence
  • Freedom to Operate
  • EPO Patent Oppositions
  • European Patent Validations
  • Anti-counterfeiting
  • Open Source & Third Party Code
Sectors
  • Energy & Environment
  • Life Sciences
  • Agritech
  • Medical Technologies
  • Chemistry
  • Transport
  • Entertainment & Creative Industries
  • Food & Drink
  • Fashion & Retail
  • Universities & Research Bodies
  • Start-ups & Spin-outs
  • Digital Transformation
    • 3D Printing
    • Artificial Intelligence
    • Blockchain
    • Data & Connectivity
    • Extended Reality
    • Industry 4.0
About Us
  • Working with us
  • Awards
  • Corporate & Social Responsibility
  • Diversity & Inclusion
  • Careers
Insights
  • Articles
  • News
  • Events
  • Resources
  • M&C Reacts

Edwin Wong

Associate

Americas
Ottawa

Get in contact

+1 613 236 9561 ewong@marks-clerk.ca
vCard

Edwin is a registered Canadian Patent Agent with particular expertise in the prosecution of biotechnology and chemical patents. Prior to joining Marks & Clerk, Edwin gained several years of experience articling and working as an associate at another Canadian intellectual property law firm.

Edwin graduated from the University of Toronto with a B.Sc. (Honours) specializing in Biochemistry, and majoring in Physics and Biology. During his undergraduate studies he gained practical research experience in a molecular biology laboratory working on CFTR, the gene responsible for causing cystic fibrosis. He subsequently obtained his law degree, also from the University of Toronto, and was called to the Ontario Bar in 2002.

In his spare time, Edwin participates in several sports and leisure activities including ultimate frisbee, badminton, skating, and chess. He also enjoys playing popular, jazz, and classical music on the piano.

Specialist in

  • Patents
  • Brands and trade marks
  • Chemistry
  • Life Sciences

Qualifications

BSc, LLB

Search our people

Latest articles by Edwin Wong

Article
- 07 January 2021

Patent protection in the time of Covid-19

It is more important than ever before for innovators in the biomedical sciences to have a sensible approach to balancing the need to protect their intellectual property rights in key markets while sharing information with other researchers.
Read more
Article
- 27 August 2020

“Indirect comparison” to Innovative Drug costs Manufacturer ANDS

In a recent decision, the Federal Court upheld the decision of Health Canada in refusing to accept Natco Pharma’s abbreviated new drug submission (ANDS) for a generic version of DESCOVY, a drug marketed by Gilead Sciences Canada in the treatment of HIV/AIDS.
Read more
Article
- 15 October 2019

Significant Changes Coming to Canadian Patent Law

Read more
Marks & Clerk logo (white)
  • Terms & Conditions
  • Privacy Notice
  • Cookies
  • Legal Notices
  • Lexology
  • Mondaq